MeSH D031901 - gestational trophoblastic disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| American Regent | Dactinomycin | Dactinomycin | 2013-08-23 | |||
| Eugia Pharma Specialties | Dactinomycin | Dactinomycin | 2017-11-09 | |||
| Hikma Pharmaceuticals | Dactinomycin | Dactinomycin | 2010-03-16 | |||
| Hisun Pharmaceutical (Hangzhou) | Dactinomycin | Dactinomycin | 2019-07-16 | |||
| Meitheal Pharmaceuticals | Dactinomycin | Dactinomycin | 2020-11-13 | |||
| Recordati | Dactinomycin | Cosmegen | 1982-01-01 | |||
| XGen Pharmaceuticals | Dactinomycin | Dactinomycin | 2019-05-20 |
Clinical Trials
Historical Success Rate
Phase 1
100%3/3
Phase 2
50%6/12
Phase 3
18%3/17
Approved: 2Overall Success rate: 9%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use